Manchin, Warren Push for Over-the-Counter Opioid Reversal Drugs (1)

April 12, 2022, 6:51 PM UTCUpdated: April 12, 2022, 9:40 PM UTC

Pfizer Inc. and other drugmakers are facing calls from Congress to make their opioid reversal drugs available over the counter, a move lawmakers claim will reduce stigmas around addiction and drug-related deaths.

Thirty lawmakers in the House and Senate are prodding Pfizer, Teva Pharmaceuticals, Hikma, Emergent BioSolutions, Amphastar Pharmaceuticals, and Adamis Pharmaceuticals to apply to the Food and Drug Administration for over-the-counter status of their respective naloxone products.

The requests come in letters sent to the drugmakers, with Sens. Joe Manchin (D-W. Va.), Elizabeth Warren (D- Mass.), and Lisa Murkowski (R-Alaska) and Reps. Alexandria Ocasio-Cortez (D-N.Y.), Rashida Tlaib ...

Learn more about Bloomberg Law or Log In to keep reading:

See Breaking News in Context

Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.

Already a subscriber?

Log in to keep reading or access research tools and resources.